Horowitz: The Stifling of COVID Treatment: The Aspirin Case Study


The war on all information that could help COVID patients survive was not limited to prescription drugs. There has been a complete breakdown of over-the-counter supplements and common medications that the public are very familiar with and readily available, which together could have reduced the burden of mortality. A new study published in the hard-hitting Journal of the American Medical Association demonstrates that it is criminal that to date our government has not counseled people on the simple use of aspirin at the first sign of COVID.

Like many other people, Advil is my first go-to medicine when I feel feverish. Yet when I thought I had COVID in July 2020 (I ultimately didn’t), even this non-physician was aware of the already solid academic literature behind the use of aspirin for COVID. So I went to the pharmacy and bought some aspirin. Now, a new study published in JAMA by researchers at George Washington University shows a slight decrease in mortality just from this well-known over-the-counter drug, even in people already hospitalized. Imagine if everyone had been instructed to have it on hand at the first sign of trouble.

The very large retrospective cohort study shows a 13.5% decrease in mortality among hospitalized patients given one baby aspirin daily. The observed benefit was even greater in people with comorbidities. Additionally, and unsurprisingly, the study found a 29% decrease in the incidence of pulmonary embolism, which is a very common factor in landing COVID patients in intensive care. The analysis included 112,269 patients hospitalized in 64 different US healthcare systems from January through September 2021. No additional incidences of adverse events were observed in the treatment group.

Another smaller study by the same lead author published last April on patients in 2020 found an even bigger benefit, possibly because the original strain was less aggressive. In the underpowered study, aspirin use was associated with a reduced risk of mechanical ventilation by 44%, ICU admission by 43%, and hospital mortality by 47%.

It’s criminal that it took two years to get this information out. Moreover, these significant but relatively modest results were for those already hospitalized, and the dosage was only 80 mg. Most doctors who have aggressively treated COVID recommend taking aspirin from day one on an outpatient basis at the first sign of trouble. One would probably assume that results would be even better with the higher dose and earlier use before microcoagulation set in in many hospitalized patients. Dr. Peter McCullough, a well-published cardiologist and internist who developed one of the first treatment protocols, noted that daily aspirin was part of his protocol for COVID patients already in 2020.

It shouldn’t have taken nearly two years for this information to be published in a high-impact journal, and even then there’s no sign that anyone in the medical establishment or the NIH is recommending its use.

Although acute COVID appears to cause severe lung inflammation and fibrosis, it was observed early in the pandemic that many people eventually died from blood clotting. That’s why FLCCC co-founder Dr. Pierre Kory tells me, “Aspirin was part of our early treatment protocol from day one.”

Dr. Bryan Tyson, who treated thousands of people in his emergency care in El Centro, California, used aspirin in the early stages of the pandemic and advised patients to take it for a while . “We started using full aspirin on an outpatient basis on our high-risk patients for 30-60 days depending on risk factors, and we’ve never seen a patient develop a pulmonary embolism or a deep vein thrombosis or a heart attack,” said one of America’s most prolific COVID doctors. . “We knew the spike protein was thrombotic, so we were more likely to use the full dose of aspirin.” Tyson, who is running for Congress in CA-25, believes it is criminal negligence for the medical professional not to preemptively treat thrombosis, which can occur early in the disease and persist for some time thereafter.

This demonstrates that the war on hydroxychloroquine and ivermectin had nothing to do with anything inherent in these drugs. We have witnessed the same blackout on non-prescription treatments such as NAC, Vitamin D, Vitamin C, Zinc, Quercetin, Pepcid, and Betadine Nasal/Oral Rinse. Imagine a multi-pronged approach, with several of them plus some anti-inflammatory prescriptions early on. Well, that’s why Dr. Tyson had such an incredible success rate treating 7,000 patients.

Most of these treatments have been outright attacked. Just as some of the studies appeared on aspirin, the entire media bizarrely carried out a coordinated attack on October 12, 2021, when the US Preventive Services Task Force overturned decades of protocol and recommended no not use aspirin to prevent heart attacks and strokes. Suddenly, anything that can be used for COVID turns into poison overnight!

The media has also savagely attacked the use of betadine nasal rinse, which studies have shown has a huge benefit in killing viral load early on.

So whether it’s widely beneficial supplements and vitamins, cheap over-the-counter drugs, safe prescription drugs, or experimental drugs used specifically for respiratory distress, nothing that might actually work has need to be approved. After all, they can only have an emergency if the public doesn’t know how to deal with it on their own.

Editor’s note: This article originally quoted Dr. Peter McCullough, referring to patients who received aspirin at the same time as the blood thinner Lovenox. The statement contained a misprinted statistic of 98% instead of 18% and has therefore been removed for clarity.


Comments are closed.